Home/Filings/4/0001209191-23-035256
4//SEC Filing

GAUGLER DARYL 4

Accession 0001209191-23-035256

CIK 0001396814other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 9:22 PM ET

Size

8.5 KB

Accession

0001209191-23-035256

Insider Transaction Report

Form 4
Period: 2023-06-05
GAUGLER DARYL
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2023-06-05$38.74/sh1,000$38,74023,591 total
  • Sale

    Common Stock

    2023-06-07$37.87/sh1,047$39,64521,539 total
  • Sale

    Common Stock

    2023-06-06$38.99/sh1,005$39,18622,586 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F2]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001928278

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 9:22 PM ET
Size
8.5 KB